Average S/N (log2)

Cluster

Detected Mass

Analysis Mode

P_Value

Formula

Metabolite ID

Ctrl

4week

8week

12week

2

1030.579

1102

0.0003

C48H78N12O13

L-Isoleucyl-L-leucyl-L-asparaginyl-L-histidyl-L-isoleucyl-L-valyl-L-prolyl-L-prolyl-L-glutamic acid

2.4

1.7

2.0

0.8

2

674.2703

1102

0.0022

C34H38N6O9

Glycyl-L-tyrosyl-L-tyrosyl-L-tryptophyl-L-serine

6.2

5.8

5.9

5.4

2

672.2733

1102

0.0039

C31H40N6O11

L-a-Aspartyl-L-tyrosyl-L-tyrosyl-L-valyl-L-asparagine

8.0

7.5

7.6

7.2

2

704.3001

1102

0.0093

C28H48N8O9S2

L-Cysteinyl-L-alanyl-L-valyl-L-valyl-L-prolyl-L-asparaginyl-L-cysteine

4.2

4.1

4.1

3.7

2

398.288

1102

0.004

C20H38N4O4

N-Acetyl-L-leucyl-L-leucyl-L-norleucinamid

2.7

2.4

2.5

1.8

3

918.3372

1102

0.0025

C43H50N8O15

Glycyl-L-a-aspartyl-L-a-glutamyl-L-tyrosyl-L-tyrosyl-L-tryptophyl-L-serine

3.0

3.1

3.2

2.8

3

817.4655

1101

0.005

C34H63N11O12

Glycyl-L-seryl-L-seryl-L-lysyl-L-seryl-L-lysyl-L-prolyl-L-lysine

2.4

2.4

2.6

2.3

Table 4: Putative molecular formula assignments and metabolite identifications for peptide fragments changed due to cholesterol treatment.